How (im)pure is continuing medical education and the marketing of drugs to physicians?
See the New York Times piece and Dan Carlat's blog perspective on the marketing of the antidepressant Lexapro.
How (im)pure is continuing medical education and the marketing of drugs to physicians?
See the New York Times piece and Dan Carlat's blog perspective on the marketing of the antidepressant Lexapro.
Leave a comment
My policy on commentsI'm adopting the policy of a blog I admire: “Comments are great; obnoxious comments get deleted. Deal." I also won’t post profanity, product pitches, or anything from anyone who doesn’t list what appears to be an actual e-mail address.